BIA - Accelerating Drug Discovery through digital and AI innovations

Emerging data technologies and AI are already identifying the drivers behind disease and discovering new approaches to diagnose and treat those diseases. This event by the BIA Science and Innovation Advisory Committee (SIAC) will help SMEs involved in discovering new therapies and diagnostics understand how they can benefit from digital tools and innovations to accelerate R&D, reduce the risks, and transform their businesses.

Case studies will be presented from organisations that have successfully used AI and digital tools in discovery, covering data generation, manipulation, and application. Further workshops are likely to follow on topics identified by attendees, so please do share your thoughts on how we can support you in this area.

If you'd like to join this event, they would be grateful if you would fill out this 5-minute survey to help them understand how best to tailor this event to your needs.

09:15   Sign in and networking

09:30   Welcome
             Justin Bryans, LifeArc

09:35   Data application - example 1
             Dan Jamieson, Biorelate

09:50   Data application - example 2

10:05   Data generation and access
             Rafael Jimenez, Medicines Discovery Catapult

10:20   Data-driven computational approaches for identifying novel therapeutic targets and drug repositioning opportunities
             Namshik Han, Milner Therapeutics Institute, University of Cambridge

10:35   Break

10:50   Live Q&A and panel discussion - chaired by Karen Wilkinson (KTN) and Liliya Serazetdinova (Earlham Institute)
             Dan Jamieson, Biorelate
             Rafael Jimenez, Medicines Discovery Catapult
             Namshik Han, Milner Institute
             Richard Goodwin, AstraZeneca

11:50   Summary and closing remarks
             Justin Bryans, LifeArc